首页> 外文期刊>Clinical and experimental pharmacology & physiology >2,3,4',5-Tetrahydroxystilbene-2-O-beta-D-Glucoside suppresses matrix metalloproteinase expression and inflammation in atherosclerotic rats.
【24h】

2,3,4',5-Tetrahydroxystilbene-2-O-beta-D-Glucoside suppresses matrix metalloproteinase expression and inflammation in atherosclerotic rats.

机译:2,3,4',5-四羟基sti-2-O-β-D-葡糖苷抑制动脉粥样硬化大鼠基质金属蛋白酶的表达和炎症。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

1. In coronary artery disease, the typical atheromatous plaque consists of a lipid core containing various inflammatory cells and a fibrous cap composed mostly of extracellular matrix. Both matrix metalloproteinases (MMPs) and inflammation are involved in the initiation of atherosclerotic plaques and plaque instability. 2. 2,3,4 cent,5-Tetrahydroxystilbene-2-O-beta-D-glucoside (TSG) reduces the blood lipid content and prevents the atherosclerotic process, but the mechanism of action of TSG is unclear. The purpose of the present study was to test whether TSG can suppress MMP activation and inflammation in atherosclerotic rats. 3. Sixty male Sprague-Dawley rats were randomly divided into six groups. Atherosclerosis was induced by feeding rats a hyperlipidaemic diet; TSG (120, 60 or 30 mg/kg per day) was administered by oral gavage. After 12 weeks of treatment, rats were killed (ethyl carbamate 1200 mg/kg) and serum lipids, C-reactive protein (CRP), interleukin (IL)-6 and tumour necrosis factor (TNF)-alpha were measured. Haematoxylin-eosin (H&E) staining was used to examine histopathological changes in the aorta. The mRNA and protein expression of MMPs were assayed by reverse transcription-polymerase chain reaction, immunohistochemistry and western blotting. Simvastatin (2 mg/kg per day) was administered as a positive control, whereas the vehicle (0.9% NaCl) group served as the untreated control. 4. In the present study, TSG significantly and dose-dependently attenuated the hyperlipidaemic diet-induced alterations in serum lipid profile and increases in CRP, IL-6 and TNF-a levels. In addition, TSG normalized the structure of the aortic wall and suppressed the expression of MMP-2 and MMP-9 at both the mRNA and protein level in the rat aortic wall. 5. In summary, TSG suppresses the expression of MMP-2 and MMP-9 and inhibits inflammation in the diet-induced atherosclerotic rats.
机译:1.在冠状动脉疾病中,典型的动脉粥样斑块由含有各种炎症细胞的脂质核心和主要由细胞外基质组成的纤维帽组成。基质金属蛋白酶(MMP)和炎症都与动脉粥样硬化斑块的形成和斑块的不稳定性有关。 2. 2,3,4 cent,5-Tetrahydroxystilbene-2-O-beta-D-glucoside(TSG)可以降低血脂含量并预防动脉粥样硬化进程,但TSG的作用机理尚不清楚。本研究的目的是测试TSG是否可以抑制动脉粥样硬化大鼠中的MMP活化和炎症。 3.将60只雄性Sprague-Dawley大鼠随机分为六组。喂高脂饮食可诱发动脉粥样硬化。通过口服强饲法给予TSG(每天120、60或30 mg / kg)。治疗12周后,处死大鼠(氨基甲酸乙酯1200 mg / kg),并测量血脂,C反应蛋白(CRP),白介素(IL)-6和肿瘤坏死因子(TNF)-α。苏木精-曙红(H&E)染色用于检查主动脉的组织病理学变化。通过逆转录-聚合酶链反应,免疫组织化学和蛋白质印迹法检测MMPs的mRNA和蛋白表达。辛伐他汀(每天2 mg / kg)作为阳性对照,而溶媒(0.9%NaCl)组作为未治疗的对照。 4.在本研究中,TSG显着并剂量依赖性地减轻了高脂血症饮食引起的血清脂质分布变化,并增加了CRP,IL-6和TNF-α水平。另外,TSG使大鼠主动脉壁结构正常化,并抑制了大鼠主动脉壁mRNA和蛋白水平上MMP-2和MMP-9的表达。 5.总而言之,TSG抑制饮食诱导的动脉粥样硬化大鼠中MMP-2和MMP-9的表达并抑制炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号